Theme A: β-Amyloid Diseases || A1.a. Disease Mechanisms, Pathophysiology: Abeta aggregation, protein misfolding
P001 - GENOME-WIDE ASSOCIATION STUDIES, FUNCTIONAL GENOMICS AND CELL BIOLOGY IDENTIFY TBC1D5 AS AN ALZHEIMER’S DISEASE-RISK GENE AND UNCOVER ITS ROLE IN OAΒ CLEARANCE.
Presentation Topic
A1.a. Disease Mechanisms, Pathophysiology: Abeta aggregation, protein misfolding
Presenter
Authors
P002 - HYDROXYPROPYL-METHYLCELLULOSE DERIVATIVE PREVENTS AMYLOID-BETA ACCUMULATION, NEUROINFLAMMATION, AND APOPTOTIC NEURODEGENERATION IN A MOUSE MODEL OF ALZHEIMER’S DISEASE
Presentation Topic
A1.a. Disease Mechanisms, Pathophysiology: Abeta aggregation, protein misfolding
Presenter
P003 - APP ACCUMULATIONS AROUND DENSE-CORE AMYLOID PLAQUES AS A NOVEL HALLMARK OF ALZHEIMER’S DISEASE
Presentation Topic
A1.a. Disease Mechanisms, Pathophysiology: Abeta aggregation, protein misfolding
Presenter
P004 - THE GENETIC LANDSCAPE FOR AMYLOID BETA NUCLEATION ACCURATELY DISCRIMINATES FAMILIAL ALZHEIMER’S DISEASE MUTATIONS
Presentation Topic
A1.a. Disease Mechanisms, Pathophysiology: Abeta aggregation, protein misfolding
Presenter
P005 - EFFECT OF ALZHEIMER’S DISEASE-RELATED Β-AMYLOID PEPTIDE CONFORMATIONS IN TRANSGENIC MOUSE MODELS OF Β-AMYLOIDOSIS
Presentation Topic
A1.a. Disease Mechanisms, Pathophysiology: Abeta aggregation, protein misfolding
Presenter
P006 - THE LUMINESCENT CONJUGATED OLIGOTHIOPHENE H-FTAA ATTENUATES TOXICITY OF THE AMYLOID-BETA PEPTIDE WITH THE ARCTIC MUTATION
Presentation Topic
A1.a. Disease Mechanisms, Pathophysiology: Abeta aggregation, protein misfolding
Presenter
P007 - MIR-277 TARGETS HID TO AMELIORATE AΒ42-MEDIATED NEURODEGENERATION IN DROSOPHILA EYE MODEL OF ALZHEIMER’S DISEASE
Presentation Topic
A1.a. Disease Mechanisms, Pathophysiology: Abeta aggregation, protein misfolding
P008 - AΒ PEPTIDES FORM ION CHANNELS IN PHOSPHOLIPID BILAYER MEMBRANES BY THE MEDIATION OF GANGLIOSIDE AT LOW CONCENTRATION
Presentation Topic
A1.a. Disease Mechanisms, Pathophysiology: Abeta aggregation, protein misfolding
P009 - PROTEOMIC ANALYSIS OF NEUROTROPHIC AND NEUROPROTECTIVE EFFECTS OF PREGNENOLONE SULFATE IN ALZHEIMER’S DISEASE
Presentation Topic
A1.a. Disease Mechanisms, Pathophysiology: Abeta aggregation, protein misfolding
Presenter
P010 - FERRITIN IRON IS CHEMICALLY REDUCED IN THE PRESENCE OF AGGREGATING Β-AMYLOID
Presentation Topic
A1.a. Disease Mechanisms, Pathophysiology: Abeta aggregation, protein misfolding
Presenter
P011 - A POTENTIAL DEFENSE MECHANISM AGAINST AMYLOID DEPOSITION IN CEREBELLUM
Presentation Topic
A1.a. Disease Mechanisms, Pathophysiology: Abeta aggregation, protein misfolding
Presenter
P013 - THE RELATIONSHIP BETWEEN THE PATH OF AMYLOID-Β FIBRIL FORMATION AND THEIR PROPERTIES.
Presentation Topic
A1.a. Disease Mechanisms, Pathophysiology: Abeta aggregation, protein misfolding
Presenter